Goutham Narla, MD, PhD
Assistant Professor, Medicine and Transformative Molecular Medicinegxn71@case.edu 216.368.3111 (o) 216.368.2968 (f)
His laboratory is focused on the identification and characterization of the key negative regulators, tumor suppressor proteins, of cancer development and progression. Dr. Narla's laboratory focuses on the mechanisms that drive cancer progression and treatment resistance to conventional and targeted molecular agents.
His accolades as a principal investigator include the Howard Hughes Medical Institute Physician-Scientist Early Career Award, and the Irma T. Hirschl / Monique Weill-Caulier Trust Scholar Award. He has over 50 publications in journals including Nature Genetics, Science, Science Translational Medicine and the Journal of Clinical Investigation.
Cancer Genetics, Cancer Biology, Cell Signaling, Oncogenes / Tumor Suppressor Genes, Alternative Splicing, Transcription Factors, Experimental Therapeutics, Mouse Models of cancer, Protein Phosphatases